Synapse - Works

Results (559)

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: Workforce challenges and training in the age of theranostics

Review

Scott, A. M.; Zeglis, B. M.; Lapi, S. E.; Scott, P. J. H.; Windhorst, A. D.; Abdel-Wahab, M.; Giammarile, F.; Piaez, D.; Jalilian, A.; Knoll, P.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Production and regulatory issues for theranostics

Review

Giammarile, F.; Paez, D.; Zimmermann, R.; Cutler, C. S.; Jalilian, A.; Korde, A.; Knoll, P.; Ayati, N.; Lewis, J. S.; Lapi, S. E.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

Review

Lapi, S. E.; Scott, P. J. H.; Scott, A. M.; Windhorst, A. D.; Zeglis, B. M.; Abdel-Wahab, M.; Baum, R. P.; Buatti, J. M.; Giammarile, F.; Kiess, A. P.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Bridging communication gaps between radiologists, referring physicians, and patients through standardized structured cancer imaging reporting: The experience with female pelvic MRI assessment using O-RADS and a simulated cohort patient group

Journal Article

Woo, S.; Andrieu, P. C.; Abu-Rustum, N. R.; Broach, V.; Zivanovic, O.; Sonoda, Y.; Chi, D. S.; Aviki, E.; Ellis, A.; Carayon, P.; more...
Academic Radiology (2024)

Fulltext@MSK | Save

Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer

Review

Browne, I. M.; André, F.; Chandarlapaty, S.; Carey, L. A.; Turner, N. C.
Lancet Oncology (2024)

Fulltext@MSK | Save

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): A phase 3, multicentre, open-label trial

Journal Article

Mahadeo, K. M.; Baiocchi, R.; Beitinjaneh, A.; Chaganti, S.; Choquet, S.; Dierickx, D.; Dinavahi, R.; Duan, X.; Gamelin, L.; Ghobadi, A.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study

Journal Article

Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
Lancet (2024)

Fulltext@MSK | Save

Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: A prospective cohort study

Journal Article

Cargo, C.; Bernard, E.; Beinortas, T.; Bolton, K. L.; Glover, P.; Warren, H.; Payne, D.; Ali, R.; Khan, A.; Short, M.; more...
The Lancet Haematology (2024)

Fulltext@MSK | Save

Imaging lung tumor metastasis with (89)Zr-DFO-crizanlizumab targeting P-selectin

Meeting Abstract

Majekodunmi, O.; Pratt, E.; Kaminsky, S.; Raashed, R.; Heller, D.; Laplant, Q.; Lewis, J.
Nuclear Medicine and Biology (2023)

Fulltext@MSK | Save

Cerenkov luminescence signal enhancement using hyperbolic metamaterials as a multi-modal imaging probe

Meeting Abstract

Boykoff, N.; Grimm, J.; O'Brien, S.
Nuclear Medicine and Biology (2023)

Fulltext@MSK | Save